Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1997 3
1999 1
2005 3
2006 6
2007 5
2008 1
2009 4
2010 6
2011 6
2012 11
2013 7
2014 7
2015 6
2016 4
2017 1
2018 5
2019 5
2020 1
2021 7
2022 7
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
CAR-NK Cells in the Treatment of Solid Tumors.
Wrona E, Borowiec M, Potemski P. Wrona E, et al. Among authors: potemski p. Int J Mol Sci. 2021 May 31;22(11):5899. doi: 10.3390/ijms22115899. Int J Mol Sci. 2021. PMID: 34072732 Free PMC article. Review.
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial.
Eng C, Kim TW, Bendell J, Argilés G, Tebbutt NC, Di Bartolomeo M, Falcone A, Fakih M, Kozloff M, Segal NH, Sobrero A, Yan Y, Chang I, Uyei A, Roberts L, Ciardiello F; IMblaze370 Investigators. Eng C, et al. Lancet Oncol. 2019 Jun;20(6):849-861. doi: 10.1016/S1470-2045(19)30027-0. Epub 2019 Apr 16. Lancet Oncol. 2019. PMID: 31003911 Clinical Trial.
Prognostic value of HER3, PTEN and p-HER2 expression in patients with HER2positive breast cancer.
Dębska-Szmich S, Kusińska R, Czernek U, Szydłowska-Pazera K, Habib-Lisik M, Piekarski JH, Olas E, Kulig A, Ułańska M, Kalinka-Warzocha E, Potemski P. Dębska-Szmich S, et al. Among authors: potemski p. Postepy Hig Med Dosw (Online). 2015 May 5;69:586-97. doi: 10.5604/17322693.1151339. Postepy Hig Med Dosw (Online). 2015. PMID: 25983297 Free article.
[PARP inhibitors--theoretical basis and clinical application].
Dębska S, Kubicka J, Czyżykowski R, Habib M, Potemski P. Dębska S, et al. Among authors: potemski p. Postepy Hig Med Dosw (Online). 2012 May 30;66:311-21. doi: 10.5604/17322693.999033. Postepy Hig Med Dosw (Online). 2012. PMID: 22706117 Free article. Review. Polish.
Noncancer Deaths in the PETACC 6 Trial.
Potemski P, Bujko K. Potemski P, et al. J Clin Oncol. 2021 Apr 10;39(11):1306. doi: 10.1200/JCO.20.03091. Epub 2021 Feb 23. J Clin Oncol. 2021. PMID: 33621110 No abstract available.
87 results